36
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Constitutive Production of the Interleukins IL-5 and IL-6 by the Lymphoma Cell Line OCI-Ly 17 Derived from a Patient with Malignant Lymphoma and Hypereosinophilia

, , , &
Pages 97-107 | Received 15 Mar 1992, Published online: 01 Jul 2009

References

  • Henderson A. H., Mejia G. Malignant lymphoma presenting with high eosinophilia, eosinophilic pleurisy and pericarditis. Thorax 1969; 24: 124–125
  • McDonald G. S. A., Hourihane D. O. B. Malignant lymphoma mimicking eosinophilic granuloma of the gut. Irish. J. Med. Sci. 1974; 143: 168–175
  • Kaufmann U., Lampert F. Eosinophiliae bei akuter lymphoblastischer Leukamie und Lymphom: Indikator fur Immunologische Vorgange?. Klin. Padiat. 1974; 186: 492–499
  • Manthorpe R., Egeberg J., Hesseloik M. Unique eosinophil granules in a case of T-cell lymphoma. Scand. J. Haematol 1977; 19: 129–144
  • Goetzl E. J., Rothenberg J., Weber E. L., Sinn C. M., Austen K. F. A novel eosinophil chemotactic factor derived from a histiocytic lymphoma of the central nervous system. Clin. Exp. Immunol 1980; 40: 249–255
  • Catovsky D., Bernasoni C., Verdonck P. J., Postma A., Hows J., Vander Don-van der Berg A., Ress J. K., Castelli G., Morra E., Galton D. A. The association of eosinophilia with lymphoblastic leukemia or lymphoma: a study of seven patients. Br. J. Haematol 1980; 45: 523–534
  • Jacobs P., Dubovsky D. W., King H. S., Bleumenthal I. Lymphocytic lymphoma, hypereosinophilia and endomyocardial fibrosis. South. Afr. Med. J. 1982; 61: 711–717
  • Reedy S. K., Hyland R. H., Alison R. E., Sturgeon J. F. G., Hutcheon M. A. Tumour-associated peripheral eosinophilia: Two unusual cases. J. Clin. Oncol. 1984; 2: 1165–1169
  • O'Shea J. J., Jaffe E. S., Lane H. C., MacDermott R. P., Fauci A. S. Peripheral T Cell lymphoma presenting as hypereosinophilia with vasculities. Am. J. Med. 1987; 82: 539–545
  • Shepherd N. A., Blackshaw A. J., Hall P. A., Bostad L., Coates P. J., Levision D. G., Morson B. C., Stansfeld A. G. Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology 1987; 11: 115–130
  • Greer J. P., York J. C., Coursar J. B., Mitchell R. T., Flexner J. M., Collins R. D., Stein R. S. Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. J. Clin. Oncol 1984; 2: 788–798
  • Metcalf D., Begley C. G., Johnson G. R., Nicola N. A., Vadas M. A., Lopez A. F., Williamson D. J., Wong G. G., Clark S. C., Wang F. A. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1986; 67: 37–45
  • Messner H. A., Yamasaki K., Jamal N., Minden M. D., Young Y. G., Wong G. D., Clark S. C. Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: Comparison with human recombinant granulocyte and granulocyte-macrophage stimulating factor. Proc. Natl. Acad. Sci. 1987; 84: 6765–6769
  • Leary A. G., Yang Y., Clark S. C., Gasson J. C., Golde D. W., Ogawa M. Recombinant gibbon interleukin 3 (IL-3) supports formation of human multilineag colonies and blast cell colonies in culture: Comparison with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). Blood 1987; 70: 1343–1348
  • Sanderson C. J., Warren D. J., Strath M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro: Its relationship to Interleukin-3, and functional properties of eosinophils produced in culture. J. Exp. Med 1985; 162: 60–74
  • Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988; 167: 219–224
  • Sonoda Y., Arai N., Ogawa M. Humoral regulation of eosinophilopoiesis in vitro: Analysis of the targets of interleukin-3 granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5. Leukemia 1989; 3: 14–18
  • Clutterbuck E. J., Hirst E. M. A., Sanderson C. J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1989; 73: 1504–1512
  • Tweeddale M., Lim B., Jamal N., Minden M. D., Messner H. A. The presence of clonogenic cells in high grade malignant lymphoma: A prognostic factor. Blood 1987; 69: 1307–1314
  • Messner H. A., Till J. E., McCulloch E. A. Interacting cell populations affecting granulopoietic colony formation by normal and leukemic human marrow. Blood 1972; 42: 701–710
  • Minden M. D., Buick B. N., McCulloch E. A. Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acture myeloblastic leukemia. Blood 1989; 54: 186–194
  • Messner H. A., Till J. E., McCulloch E. A. Density distributions of marrow cells from mouse and man. Ser. Haematol. 1972; 22: 1972–1981
  • Takahashi T., Lim B., Wandl U., Minden M. D., Messner H. A. Human myeloma cell lines raised from myeloma colonies of bone marrow or peripheral blood samples, Manuscript in preparation
  • Schumacker J. H., Ogarra A., Shrader B., Van Kiimmenade A., Bond M. W., Mosmann T. R., Coffman R. L. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 1988; 141: 1576–1581
  • Yamasaki K., Solberg L. A., Jamal N., Lockwood G., Tritcher D., Curtis G. E., Minden M. D., Mann K. G., Messner H. A. Hemopoietic colony growth-promoting activites in the plasma of bone marrow transplant recipients. J. Clin. Invest. 1988; 82: 255–261
  • Warnke R., Levy R. Detection of T and B cell antigens with hybridoma monoclonal antibodies: A biotin avidin-horseradish peroxidase method. J. Histochem. Cyto-chem. 1980; 28: 771–778
  • Cheng G. Y., Minden M. D., Toyonaga B., Mak T. W., McCulloch E. A. T-cell receptor and immunoglobulin gene rearrangements in acute myeloblasts leukemia. J. Exp. Med. 1986; 163: 414–420
  • Chirgwin J. M., Prxhyla A. E., McDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5304
  • Furutani Y., Notke M., Yamayoshi M., Yamagishi J., Nomura H., Ohue M., Furuta R., Fukui T. Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. Nucleic. Acid. Res. 1985; 13: 5869–5882
  • Yokota T., Otsuka T., Mosmann T., Banchereau J., Defrance T., Blanchard D., Deveries J. E., Lee F. Isolation and characterization of a human interleukin cDNA clone homologous to mouse B-cell stimulatory factor 1, that expresses B-cell and T-cell stimulating activities. Proc. Natl. Acad. Set 1986; 83: 5894–5898
  • Yang Y. C., Ciarletta A. B., Temple P. A., Chung M. P., Kovaic S., Witek-Giannotti J. S., Leary A. C., Kritz R. Human IL-3 (Multi-CSF): Identification by expression cloning of a novel hemopoietic growth factor related to murine IL-3. Cell 1986; 47: 3–10
  • Zilberstein A., Ruggieri R., Korn J. H., Ravel M. Structure and expression of cDNA and genes for human IFNB2, a distinct species inducible by growth stimulatory cytokines. EM BO J. 1986; 5: 871–882
  • Wong G. G., Witzek J. S., Temple P. A., Wilken K. M., Leary A. C., Luxenberg D. P., Jones S. S., Brown E. L. Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1988; 228: 810–815
  • Kinashi T., Harada N., Severinson E., Tanabe T., Slideras P., Konishi M., Azuma C., Tminaga A., Bergstedt-Lindqvist S., Takahashi M., Matsuda F., Yaoita Y., Takatsu K., Honjo T. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 1986; 324: 70–73
  • Weiss L. O., Crabtree G. S., Rouse R. V., Warnke R. A. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am. J. Pathol. 1985; 118: 316–320
  • Horning S. J., Weiss L. O., Crabtree G. S., Warnke R. A. Clinical and phenotypic diversity of T-cell lymphomas. Blood 1986; 62: 1579–1586
  • Minden M. D., Personal communication.
  • Wright D. H. T cell lymphomas. Histopathology 1986; 10: 321–326
  • Goetzl E. J., Tashjian A. H., Rubin R. H., Austen K. F. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. J. Clin. Invest. 1978; 61: 770–779
  • Freeman G. J., Freedman A. S., Rabinowe S. N., Segil J. M., Horowitz J., Rosen K., Whitman J. F., Nadler L. M. Interleukin 6 gene expression in normal and neoplastic B cells. Journal of Clinical Investigation 1989; 83: 1512–1518
  • Yee C., Biondi A., Wang X. H., Iscove N. N., Sousa J. D., Arden L. A., Wong G. G., Clark S. C., Messner H. A., Minden M. D. A possible autocrine role for interleukin 6 in two lymphoma cell lines. Blood 1989; 74: 798–804
  • Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramotor A., Kishimoto T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 1988; 332: 83–85
  • Hitzler J. K., Matinez-Valdez H, Bergsagel D. B., Minden M. D., Messner H. A. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-MY 1 to 7 established from patients with advanced stage of the disease. Blood 1991; 78: 1996–2004
  • Zhang X. G., Klein B., Bataille R. Interleukin 6 is a potent myeloma cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 73: 517–526
  • Tweeddale M., Jamal N., Nguyen A., Wang X. H., Minden M. D., Messner H. A. Production of growth factors in malignant lymphoma cell lines. Blood 1989; 74: 572–578
  • Keating M., Williams L. T. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 1988; 239: 914–918
  • Daubar C. E., Browder T. M., Abrams J. S., Nienhuis A. W. COOH-terminal-modified interleukin-3 is related intracellularly and stimulates autocrine growth. Science 1989; 245: 1493–1498
  • Coffman R. L., Seymour B. N. P., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245: 308–310
  • Owen W. F., Rothernberg M. E., Peterson J., Weller P. F., Selberstein D., Sheffer A. L., Stenvens R. L., Soberman R. J., Austen K. F. Interleukin-5 and phenotypically altered eosinophils in the blood of patients with idiopathic hypereosinophilic syndrom. Journal of Experimental Medicine 1989; 170: 343–348
  • Enokihara H., Kajitani H., Nagashima S., Tsunogake S., Takano N., Saito K., Furusawa S., Shishido H., Hitoshi Y., Takatsu K. Interleukin 5 activity in sera from patients with eosinophilia. British Journal of Haematology 1990; 75: 485–492
  • Hamid B., Azzawi M., Ying S., Moqbel R., Wardlaw A. J., Corrigan C. J., Bradley B., Durham S. R., Collin J. V., Jeffery P. K., Quint D. J., Kay A. B. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. Journal of Clinical Investigation 1991; 87: 1541–6
  • Samoszuk M., Nansen L. Detection of interleukin-5 messenger mRNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1989; 75: 13–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.